Home  |  Site Map  |  Glossary  | Contact
DEC 30 QLT Acquires Early-Stage Ophthalmic Asset for US$7.5 Million
   
DEC 22 QLT Inc. Establishes Sales Force in the United States
   
DEC 15 QLT Initiates Phase Ib of QLT091001 in Leber Congenital Amaurosis
   
DEC 09

6-Month Results From EVEREST Study Evaluating Visudyne® Therapy in Patients with Polypoidal Choroidal Vasculopathy

   
2009 Q4 & Year-end Results Conference Call
QLT will hold an investor call to discuss Q4 and year-end 2009 financial results on Wednesday, March 10 at 8:30 am ET. To receive an e-mail reminder for the call, click here.
 

2009 Q3 Results Conference Call
QLT held an investor call to discuss Q3 2009 financial results on Tuesday, October 27 at 8:30 am ET. To listen to a replay of the webcast, click here.

 
 
 
 
 
 
 
 
 
 
Copyright © 2000-2009 QLT Inc. Legal Terms for use of site and Privacy Policy | Disclaimer
Vancouver Web Design by Graphically Speaking
 
Employee Login